Rare Diseases in Malaysia: Mapping the Landscape and Building a Framework for Comprehensive Care Support

Caring for Rare Diseases in Malaysia
Vol. 21 No. 2 : 2026 (1010-1019)

Juen Kiem Tan
Juen Kiem Tan
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia / Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Ching Soong Khoo
Ching Soong Khoo
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Rabani Remli
Rabani Remli
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia / Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Nor Syazwani Chamhuri
Nor Syazwani Chamhuri
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia / Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Siti Hajar Mat Desa
Siti Hajar Mat Desa
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia / Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Rathika Rajah
Rathika Rajah
Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Norfazilah Ahmad
Norfazilah Ahmad
Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
Hui Bein Chew
Hui Bein Chew
Department of Genetics and Inherited Metabolic Diseases, Kuala Lumpur General Hospital, 50586 Kuala Lumpur, Malaysia
Lock Hock Ngu
Lock Hock Ngu
Department of Genetics and Inherited Metabolic Diseases, Kuala Lumpur General Hospital, 50586 Kuala Lumpur, Malaysia
Norlinah Mohamed Ibrahim
Norlinah Mohamed Ibrahim
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia / Hospital Canselor Tuanku Muhriz, Cheras, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia

Abstract
Rare diseases (RDs) represent an emerging global health issue affecting an estimated 5.9% of the world’s population, with over 8,000 conditions identified and counting. In Malaysia, RDs are defined as diseases affecting fewer than one in 4,000 people. These patients face significant barriers, which include limited awareness among healthcare providers, delayed diagnoses, insufficient healthcare coverage and restricted access to orphan drugs. This article proposes a framework to tackle the issues mentioned by enhancing public and professional awareness, establishing national RD registries, encouraging local and international collaborations, and creating dedicated funding schemes. These points aim to improve early diagnosis, equitable access to treatment, and overall patient care. By addressing these management and treatment gaps, we can work towards a more comprehensive and effective RD management framework.

Keywords : Accessibility; health service; national policy,

Correspondance Address
norlinah@hctm.ukm.edu.my

References

Abozaid, G.M., Kerr, K., McKnight, A., Al-Omar, H.A. 2022. Criteria to define rare diseases and orphan drugs: A systematic review protocol. BMJ Open 12(7): e062126. https://doi.org/10.1136/bmjopen-2022-062126

AHRQ Methods for Effective Health Care. 2014. In: Gliklich, R.E., Dreyer, N.A., Leavy, M.B. (eds.). Registries for Evaluating Patient Outcomes: A User’s Guide. Rockville (MD): Agency for Healthcare Research and Quality (US).

Aizawa, Y., Watanabe, A., Kato, K. 2021. Institutional and social issues surrounding genetic counselors in Japan: Current challenges and implications for the global community. Front Genet 12: 646177. https://doi.org/10.3389/fgene.2021.646177

Amini, F., Kin, W.Y., Kolandaiveloo, L. 2014. Physicians’ knowledge and perception of gene profiling in Malaysia. Int J Med Health Biomed Pharm Eng 8(12): 841–845.

Angelis, A., Aggarwal, A., Miners, A., Grieve, R., Cairns, J., Briggs, A. 2023. The innovative medicines fund: A universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep? J R Soc Med 116(10): 324–330. https://doi.org/10.1177/01410768231192476

Benito-Lozano, J., López-Villalba, B., Arias-Merino, G., Posada De La Paz, M., Alonso-Ferreira, V. 2022. Diagnostic delay in rare diseases: Data from the Spanish rare diseases patient registry. Orphanet J Rare Dis 17(1): 418. https://doi.org/10.1186/s13023-022-02530-3

Boycott, K.M., Rath, A., Chong, J.X., Hartley, T., Alkuraya, F.S., Baynam, G., Brookes, A.J., Brudno, M., Carracedo, A., Den Dunnen, J.T., et al. 2017. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet 100(5): 695–705. https://doi.org/10.1016/j.ajhg.2017.04.003

Chambers, J.D., Panzer, A.D., Kim, D.D., Margaretos, N.M., Neumann, P.J. 2019. Variation in US private health plans’ coverage of orphan drugs. Am J Manag Care 25(10): 508–512.

Choi, S.A., Lim, K., Baek, H., Yoo, S., Cho, A., Kim, H., Hwang, H., Kim, K.J. 2021. Impact of mobile health application on data collection and self-management of epilepsy. Epilepsy Behav 119: 107982. https://doi.org/10.1016/j.yebeh.2021.107982

Chua, H.T., Cheah, J.C. 2012. Financing universal coverage in Malaysia: A case study. BMC Public Health 12(Suppl 1): S7. https://doi.org/10.1186/1471-2458-12-S1-S7

Chung, C.C.Y., Chu, A.T.W., Chung, B.H.Y. 2022. Rare disease emerging as a global public health priority. Front Public Health 10: 1028545. https://doi.org/10.3389/fpubh.2022.1028545

Conduah, A.K., Ofoe, S., Siaw-Marfo, D. 2025. Data privacy in healthcare: Global challenges and solutions. Digit Health 11: 20552076251343959. https://doi.org/10.1177/20552076251343959

Drell, D., De Silva, A., Lee, C. 2022. What rare disease patient advocacy groups are doing to mitigate the effects of disparities. Adv Pulm Hypertens 21(2): 35–43. https://doi.org/10.21693/1933088X-21.2.35

Elsalti, A., Darkhabani, M., Alrifaai, M.A., Mahroum, N. 2023. Celebrities and medical awareness: The case of Celine Dion and stiff-person syndrome. Int J Environ Res Public Health 20(3): 1936. https://doi.org/10.3390/ijerph20031936

Farhani, S., Roslina, A.J., Nik Mazlina, M., Noor Hasliza, H., Lih Bing, L., Noorul Amilin, S., Zienna Zufida, Z.R., Siti Khalimah, R. 2024. Utilisation of the web-based Home Assessment Tool among patients with COVID-19 in Selangor, Malaysia: An observational study. Malays Fam Physician 19: 19. https://doi.org/10.51866/oa.205

Faye, F., Crocione, C., Anido De Peña, R., Bellagambi, S., Escati Peñaloza, L., Hunter, A., Jensen, L., Oosterwijk, C., Schoeters, E., De Vicente, D., Faivre, L., Wilbur, M., Le Cam, Y., Dubief, J. 2024. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: Results of a Rare Barometer retrospective patient survey. Eur J Hum Genet 32(9): 1116–1126. https://doi.org/10.1038/s41431-024-01604-z

Gong, L., He, Q. 2021. Establishing a rare diseases center: Experiences from Western China. Intractable Rare Dis Res 10(1): 60–61. https://doi.org/10.5582/irdr.2020.03091

Groft, S.C., Posada De La Paz, M. 2017. Rare diseases: Joining mainstream research and treatment based on reliable epidemiological data. Adv Exp Med Biol 1031: 3–21. https://doi.org/10.1007/978-3-319-67144-4_1

Groft, S.C., Posada, M., Taruscio, D. 2021. Progress, challenges and global approaches to rare diseases. Acta Paediatr 110(10): 2711–2716. https://doi.org/10.1111/apa.15974

Haidle, J.L., Sternen, D.L., Dickerson, J.A., Mroch, A., Needham, D.F., Riordan, C.M., Kieke, M.C. 2017. Genetic counselors save costs across the genetic testing spectrum. Am J Manag Care 23(10 Spec No.): Sp428–Sp430.

Hristova-Atanasova, E., Iskrov, G., Atanasov, I., Genc, A., Stefanov, R. 2023. What is the awareness of rare diseases among medical students? A survey in Bulgaria. Orphanet J Rare Dis 18(1): 213. https://doi.org/10.1186/s13023-023-02820-4

Jamal, M.H., Abdul Aziz, A.F., Aizuddin, A.N., Aljunid, S.M. 2023. Gatekeepers in the health financing scheme: Assessment of knowledge, attitude, practices, and participation of Malaysian private general practitioners in the PeKa B40 scheme. PLoS One 18(10): e0292516. https://doi.org/10.1371/journal.pone.0292516

Kanchan, S., Gaidhane, A. 2023. Social media role and its impact on public health: A narrative review. Cureus 15(1): e33737. https://doi.org/10.7759/cureus.33737

Katakowski, J.A., López, J.C. 2025. Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunities. Drug Discov Today 30(4): 104346. https://doi.org/10.1016/j.drudis.2025.104346

Li, X., Zhang, X., Zhang, S., Lu, Z., Zhang, J., Zhou, J., Li, B., Ou, L. 2021. Rare disease awareness and perspectives of physicians in China: A questionnaire-based study. Orphanet J Rare Dis 16(1): 171. https://doi.org/10.1186/s13023-021-01788-3

Lone, R., Alatoom, A., Nabi, A., Mathur, B., Habou, M., Monga, R., Varghese, R., Daniel, S., Hooda, S.K., Joseph, S., Alhumaidan, H.S.O. 2025. Microbiology laboratory consolidation: Optimising diagnostic efficiency and service quality: A case study from Dubai Health, United Arab Emirates. IJID Reg 17: 100779. https://doi.org/10.1016/j.ijregi.2025.100779

Marwaha, S., Knowles, J.W., Ashley, E.A. 2022. A guide for the diagnosis of rare and undiagnosed disease: Beyond the exome. Genome Med 14(1): 23. https://doi.org/10.1186/s13073-022-01026-w

McCabe, C., Claxton, K., Culyer, A.J. 2008. The NICE cost-effectiveness threshold. Pharmacoeconomics 26(9): 733–744. https://doi.org/10.2165/00019053-200826090-00004

McClendon-Weary, B., Putnick, D.L., Robinson, S., Yeung, E. 2020. Little to give, much to gain: What can you do with a dried blood spot? Curr Environ Health Rep 7(3): 211–221. https://doi.org/10.1007/s40572-020-00289-y

Morgan, G., Subbiah, V. 2023. Rare disease research powered by empowered patients: Solving the zebra puzzle through social media. Cancer 129(14): 2128–2131. https://doi.org/10.1002/cncr.34765

Murdock, L., Taylor & Francis, L., Stephenson, R. 2024. Advancing translational research. J Transl Res 1(1): 2432753. https://doi.org/10.1080/29947448.2024.2432753

Mustapa, F.D., Mustapa, M., Ismail, F., Kherun, N. 2004. Outsourcing in Malaysian healthcare support services: A study on the causes of increased operational costs. Master’s thesis. University College London, London.

Ng, Q.X., Ong, C., Chan, K.E., Ong, T.S.K., Lim, I.J.X., Tang, A.S.P., Chan, H.W., Koh, G.C.H. 2024. Comparative policy analysis of national rare disease funding policies in Australia, Singapore, South Korea, the United Kingdom and the United States: A scoping review. Health Econ Rev 14(1): 42. https://doi.org/10.1186/s13561-024-00519-1

Nguengang Wakap, S., Lambert, D.M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., Rath, A. 2020. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet 28(2): 165–173. https://doi.org/10.1038/s41431-019-0508-0

Ormond, K.E., Abad, P.J., Macleod, R., Nishigaki, M., Wessels, T.M. 2024. The global status of genetic counselors in 2023: What has changed in the past 5 years? Genet Med Open 2(Suppl 2): 101887. https://doi.org/10.1016/j.gimo.2024.101887

Patterson, A.M., O’Boyle, M., Vannoy, G.E., Dies, K.A. 2023. Emerging roles and opportunities for rare disease patient advocacy groups. Ther Adv Rare Dis 4: 26330040231164425. https://doi.org/10.1177/26330040231164425

Pop, B., Fetica, B., Blaga, M.L., Trifa, A.P., Achimas-Cadariu, P., Vlad, C.I., Achimas-Cadariu, A. 2019. The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1): 7–14. https://doi.org/10.15386/cjmed-1015

Powell, J., Pring, T. 2024. The impact of social media influencers on health outcomes: Systematic review. Soc Sci Med 340: 116472. https://doi.org/10.1016/j.socscimed.2023.116472

Prince, A.E.R., Uhlmann, W.R., Suter, S.M., Scherer, A.M. 2021. Genetic testing and insurance implications: Surveying the US general population about discrimination concerns and knowledge of the Genetic Information Nondiscrimination Act (GINA). Risk Manag Insur Rev 24(4): 341–365. https://doi.org/10.1111/rmir.12195

Richesson, R., Vehik, K. 2010. Patient registries: Utility, validity and inference. Adv Exp Med Biol 686: 87–104. https://doi.org/10.1007/978-90-481-9485-8_6

Runheim, H., Pettersson, M., Hammarsjö, A., Nordgren, A., Henriksson, M., Lindstrand, A., Levin, L., Soller, M.J. 2023. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Sci Rep 13(1): 6904. https://doi.org/10.1038/s41598-023-33787-8

Saman, J.A., Valinejadi, A., Mohammadi, S., Karimpor, H., Mirzaei, M., Kawyannejad, R. 2020. Assessment of relationship between the use of cell phone and social networks and sleep quality in students of medical sciences: A cross-sectional study. Interv Med Appl Sci 11(3): 131–135. https://doi.org/10.1556/1646.10.2018.30

Shafie, A.A., Chaiyakunapruk, N., Supian, A., Lim, J., Zafra, M., Hassali, M.A.A. 2016. State of rare disease management in Southeast Asia. Orphanet J Rare Dis 11(1): 107. https://doi.org/10.1186/s13023-016-0460-9

Shafie, A.A., Supian, A., Ahmad Hassali, M.A., Ngu, L.H., Thong, M.K., Ayob, H., Chaiyakunapruk, N. 2020. Rare disease in Malaysia: Challenges and solutions. PLoS One 15(4): e0230850. https://doi.org/10.1371/journal.pone.0230850

Shi, Z., Zhang, Q., Wang, X. 2023. Does the disclosure of medical insurance information affect patients’ willingness to adopt the diagnosis-related groups system? Front Public Health 11: 1136178. https://doi.org/10.3389/fpubh.2023.1136178

Sinan, I., Mihdawi, M., Farahat, A.R., Fida, M. 2023. Knowledge and awareness of rare diseases among healthcare professionals in the Kingdom of Bahrain. Cureus 15(10): e47676. https://doi.org/10.7759/cureus.47676

Sohn, E. 2017. Fundraising: The ice bucket challenge delivers. Nature 550(7676): S113–S114. https://doi.org/10.1038/550S113a

Thangiah, G., Said, M.A., Majid, H.A., Reidpath, D., Su, T.T. 2020. Income inequality in quality of life among rural communities in Malaysia: A case for immediate policy consideration. Int J Environ Res Public Health 17(23): 8731. https://doi.org/10.3390/ijerph17238731

Velvin, G., Dammann, B., Haagensen, T., Johansen, H., Strømme, H., Geirdal, A., Bathen, T. 2023. Work participation in adults with rare genetic diseases: A scoping review. BMC Public Health 23(1): 910. https://doi.org/10.1186/s12889-023-15654-3

Willmen, T., Willmen, L., Pankow, A., Ronicke, S., Gabriel, H., Wagner, A.D. 2023. Rare diseases: Why is a rapid referral to an expert center so important? BMC Health Serv Res 23(1): 904. https://doi.org/10.1186/s12913-023-09886-7

Yang, G., Cintina, I., Pariser, A., Oehrlein, E., Sullivan, J., Kennedy, A. 2022. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis 17(1): 163. https://doi.org/10.1186/s13023-022-02299-5

Yoo, H.W. 2024. Development of orphan drugs for rare diseases. Clin Exp Pediatr 67(7): 315–327. https://doi.org/10.3345/cep.2023.00535

Yu, C.P., Whynes, D.K., Sach, T.H. 2008. Equity in health care financing: The case of Malaysia. Int J Equity Health 7(1): 15. https://doi.org/10.1186/1475-9276-7-15


Barriers to treatment and an integrated framework for enhanced support for rare diseases. Created by the authors using Canva (Canva Pty Ltd., Sydney, Australia)